Figure 2C presents the expression of 6 hub genes in patients. Since higher expression of C1orf228, FUZ, and SIRPG was associated with better survival of BC patients in the training set, these three genes had a lower expression in the high-risk subgroup than the low-risk subgroup. This evidence concerns the gene SIRPG and breast cancer.